Westport cardiologist says new blood pressure guidelines aren’t good for all

Friday, March 9, 2018
BRIDGEPORT, CT (March 8, 2018) – Adam E. Schussheim, MD, MSc, of Westport, a member of Northeast Medical Group’s Cardiac Specialists and attending physician at Bridgeport Hospital, was the senior author of the article, “Impact of cardiovascular risk on the relative benefit and harm of intensive treatment of hypertension,” published by the Journal of the American College of Cardiology, a leading medical journal in the field of cardiovascular disease. (The online version of the article was posted March 7 and the print version will appear in the April 17 issue of the journal.)

Dr. Schussheim and his colleagues investigated the impact of new guidelines issued in November that redefine high blood pressure. Dr. Schussheim, an expert in cardiovascular disease with subspecialty accreditations in cardiovascular imaging, lipidology, and hypertension, says while patients at higher risk for cardiovascular disease benefited from the stricter guidelines, those with lower risk experienced more harm than benefit from the intensive treatment recommendations.

“Clearly, more intensive treatment goals are appropriate for a segment of the population,” Dr. Schussheim said, “but our study suggests that we can be smarter about who is more likely to benefit from these aggressive targets and thus we can minimize potential side effects.”

The study by Dr. Schussheim and his colleagues may be able to refine the guidance of a recent panel recommendation for blood pressure. The new rules were issued by the American Heart Association, American College of Cardiology and nine other professional health organizations and classify hypertension as a reading of 130 systolic over 80 diastolic, rather than the previous targets of 140 over 90. Under these new tightened rules, 46 percent of U.S. adults are now considered hypertensive, up from 32 percent.

The call for more aggressive treatment is based largely on data from the Systolic Blood Pressure Intervention Trial, or SPRINT, which was a large-scale study of more than 9,000 people, sponsored by the NIH’s National Heart, Lung and Blood Institute. Dr. Schussheim’s study was a subsequent analysis of the SPRINT database and identified sub-populations even more likely to benefit from these lower targets.

Other researchers collaborating with Schussheim on this paper include Robert A Phillips, MD, PhD, Houston Methodist’s chief medical officer, Jiaqiong Xu, Ph.D., Leif E. Peterson, PhD, MPH, and Ryan M. Arnold, MPH, from Houston Methodist and Joseph A. Diamond, MD, cardiology department of Hofstra Northwell School of Medicine in Hempstead, NY.
Northeast Medical Group (NEMG) is a not-for-profit multispecialty medical foundation established in 2010. NEMG integrates physicians across Yale New Haven Health and helps provide more coordinated, comprehensive, safe and high quality health care for patients across the entire continuum – primary, specialty, inpatient, outpatient, rehabilitative and preventive care. NEMG represents more than 120 locations and 835 physicians and medical professionals affiliated with Bridgeport, Greenwich, Lawrence + Memorial, Westerly and Yale New Haven hospitals. www.northeastmedicalgroup.org

Similar Articles

03/24/20

Bridgeport Hospital starts COVID-19 testing in Milford

BRIDGEPORT, CT (March 24, 2020) – As part of its ongoing efforts to protect patients and healthcare workers from exposure to coronavirus (COVID-19), Bridgeport Hospital today opened a second appointment-only, drive-through testing station at the Boston Post Road Medical Center, 831 Boston Post Road, Milford.

03/21/20

Visitation policy explained to help fight coronavirus (COVID-19) spread

New Haven, CT (March 21, 2020) – Due to the continued concern regarding coronavirus (COVID-19), all Yale New Haven Health facilities have limited visitor access to patients at the hospitals as well as outpatient facilities in Connecticut, New York and Rhode Island, including Northeast Medical Group offices. We understand that this can be very upsetting to both patients and family members and we ask for your patience as we go through these unprecedented times.

03/09/20

Media Statement: COVID-19 patient receiving care at Bridgeport Hospital

Bridgeport, CT (March 9, 2020) - Bridgeport Hospital can confirm that it is currently caring for a patient that has tested positive for COVID-19. The Hospital is well prepared and has taken every precaution to ensure the health and safety of all patients, staff and employees.